Cat. No. | Product name | CAS No. |
DC5204 |
OG-L002
Featured
OG-L002 is a potent and specific LSD1 inhibitor with IC50 of 20 nM, exhibiting 36- and 69-fold selectivity over MAO-B and MAO-A, respectively. |
1357302-64-7 |
DC9985 |
OICR9429
Featured
OICR-9429 is a potent and selective chemical probe suitable to help dissect the biological role of WDR5 (Kdisp < 100 nM). |
1801787-56-3 |
DC9059 |
Olanzapine
Featured
Olanzapine(LY170053) is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist. |
132539-06-1 |
DC4110 |
AZD-2281 (Olaparib)
Featured
Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1 and PARP2 with IC50 of 5 nM and 1 nM, respectively. |
763113-22-0 |
DC9396 |
Olcegepant
Featured
Olcegepant(BIBN 4096; BIBN 4096BS) is the first potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor(IC50= 0.03 nM). |
204697-65-4 |
DC23372 |
Olinone
Featured
Olinone is a selective inhibitor for the BET BRD1 with Kd of 3.4/3.7/8.6 uM for BRD4-BrD1/BRD3-BrD1/BRD2-BrD1, respectively, shows high selectivity over BET BRD2 (Kd>300 uM). |
1770789-37-1 |
DC10384 |
Olodaterol
Featured
Olodaterol (BI1744) is a long acting β2-adrenoceptor agonist with an EC50 of 1.4±0.08 nM. |
868049-49-4 |
DC9248 |
Olodaterol(BI-1744) hydrochloride
Featured
Olodaterol is a novel, long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. |
869477-96-3 |
DC9577 |
Olprinone (Hydrochloride)
Featured
Olprinone Hcl(Loprinone Hcl) is a selective phosphodiesterase 3 (PDE3) inhibitor. |
119615-63-3 |
DC8390 |
Oltipraz
Featured
Oltipraz is a potent Nrf2 activator and a potent inducer of Phase II detoxification enzymes, most notably glutathione-S-transferase (GST). Phase 3. |
64224-21-1 |
DC12281 |
Olutasidenib (FT-2102)
Featured
Olutasidenib is a highly potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 that could be used in the treatment of acute myeloid leukemia. |
1887014-12-1 |
DC10365 |
Omadacycline (tosylate)
Featured
Omadacycline is novel, aminomethyl tetracycline antibiotic being developed for the treatment of community-acquired bacterial infections. |
1075240-43-5 |
DC7023 |
Ombrabulin
Featured
Ombrabulin (AVE8062) hydrochloride is a synthetic derivative of CA-4-P, which inhibits growth in a large number of drug-resistant animal tumors and carcinogen-induced tumors. |
181816-48-8 |
DC10054 |
Ombrabulin hydrochloride
Featured
Ombrabulin (AVE8062) hydrochloride is a synthetic derivative of CA-4-P, which inhibits growth in a large number of drug-resistant animal tumors and carcinogen-induced tumors. |
253426-24-3 |
DC5195 |
Omecamtiv mecarbil (CK-1827452)
Featured
Omecamtivmecarbil (CK-1827452) is a specific cardiac myosinactivator and a clinical drug for left ventricular systolic heart failure. |
873697-71-3 |
DC11043 |
Omidenepag
Featured
Omidenepag is a potent, selective agonist human EP2 receptor with binding IC50/EC50 of 10/1.7 nM, >500-fold selectivity over EP1, EP3 and EP4 receptors; Omidenepag is the active form of Omidenepag Isopropyl (OMDI). |
1187451-41-7 |
DC11044 |
Omidenepag Isopropyl
Featured
Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor; demonstrates excellent IOP-lowering activities following ocular administration in ocular normotensive monkeys, Omidenepag Isopropyl (OMDI) is a clinical candidate for the treatment of glaucoma. |
1187451-19-9 |
DC12164 |
ON-013100
Featured
ON-013100, an antineoplastic drug, acts a mitotic inhibitor that could inhibit Cyclin D1 expression. |
865783-95-5 |
DC9927 |
ON1231320
Featured
ON1231320 is a potent selective inhibitor of Polo like kinase 2 (PLK2). |
1312471-39-8 |
DC9253 |
ON123300
Featured
ON123300 is a novel multiple kinase inhibitor. |
1357470-29-1 |
DC11417 |
ONC 212
Featured
ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer drug and also a selective agonist of GPR132. |
1807861-48-8 |
DC8137 |
Oncrasin 1
Featured
Oncrasin 1 is a proapoptotic substance. Induces abnormal nuclear aggregation of PKCι and suppressing RNA transcription. |
75629-57-1 |